Ms Diana Watral > Kirkland & Ellis LLP > Chicago, United States > Lawyer Profile
Kirkland & Ellis LLP Offices
![Kirkland & Ellis LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/53111.jpg?v=1653404175)
333 West Wolf Point Plaza
Chicago, IL 60654
United States
- Firm Profile
- Go to...
Ms Diana Watral
![Diana Watral photo](https://www.legal500.com/wp-content/uploads/sites/13/2023/07/53111_1184454.jpg)
Position
Diana Watral is a litigation partner and trial lawyer in Kirkland’s Chicago office. Diana represents companies as both plaintiffs and defendants in a broad range of business and intellectual property disputes, with recent experience in contract, False Claims Act, trade secret, patent, sports, products liability, and complex commercial cases.
Most recently, Diana served as trial counsel to Flexus Biosciences, a Bristol-Myers Squibb subsidiary, in a $1 billion trade secret jury trial that resulted in a complete defense verdict. Diana successfully defended Abbott in a $1 billion False Claim Act jury trial and second-chaired Baxter Healthcare’s successful defense of a $400 million contract dispute. She also successfully defended a TRO and injunction request seeking to prevent the Chicago Cubs from expanding Wrigley Field.
Lawyer Rankings
United States > Dispute resolution > General commercial disputes
(Next Generation Partners)Kirkland & Ellis LLP‘s litigation practice group comes highly recommended as ‘very experienced in all areas of commercial litigation’, drawing on the team’s deep bench of ‘top drawer legal talent’ to handle complex cases spanning the entire breadth of industry sectors and substantive areas, including Congressional inquiries, securities litigation, class action claims, government investigations and white-collar crime. Leading practitioner Mark Filip splits his time between Washington DC and Chicago and is a go-to name for government enforcement defense and internal investigations. Pre-eminent trial lawyer Jim Hurst is well-regarded for his advice in aspects of complex commercial litigation, having recently spearheaded the firm’s successful defence of Abbott Laboratories in multi-district litigation arising out of a recall of infant formula. Diana Watral represents high-end clients in a broad range of disputes, including contract, False Claims Act, trade secret, antitrust, patent, sports, and product liability cases. New York’s Sandra Goldstein is an important port of call for securities litigation, fraud class actions and business-critical commercial disputes. All lawyers named are based in Chicago unless otherwise specified.
Lawyer Rankings
- General commercial disputes United States > Dispute resolution
- Next Generation Partners United States > Dispute resolution > General commercial disputes
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade > Customs, export controls and economic sanctions
- Energy > Energy regulation: oil and gas
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism